P06213 (INSR_HUMAN) Homo sapiens (Human)

Insulin receptor UniProtKBInterProSTRINGInteractive Modelling

1382 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

56 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
tentative model of the human insulin receptor ectodomain bound by three insulin Heteromer
P01308;
28-956
Assess
human insulin receptor ectodomain bound by 4 insulin Heteromer
P01308;
28-956
Assess
Structure of the human insulin receptor ectodomain, IRDeltabeta construct, in complex with four Fab… Heteromer
A2P1G9; P01837; P01865; U5LP42;
28-949
NAG;NAG;NAG;NAG;NAG;
Assess
Cryo-EM structure of full-length insulin receptor bound to 4 insulin. 3D refinement was focused on … Heteromer
A6XGL2;
28-949
Assess
Insulin receptor ectodomain dimer complexed with two IRPA-3 partial agonists Heteromer
P01308;
28-949
Assess
The insulin receptor ectodomain in complex with four venom hybrid insulins - symmetric conformation Heteromer
P01308;
28-949
20×NAG;
Assess
Leg region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-… Heteromer
P08069;
28-949
NAG;NAG;NAG;
Assess
Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin with visible dd… Heteromer
P01308;
28-946
Assess
Low resolution Cryo-EM structure of the full-length insulin receptor bound to 3 insulin, conf 2 Heteromer
P01308;
28-946
Assess
Low resolution Cryo-EM structure of the full-length insulin receptor bound to 2 insulin, conf 3 Heteromer
P01308;
28-946
Assess
Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin, conf 1 Heteromer
P01308;
28-946
Assess
Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 2 In… Heteromer
P01308;
32-852
Assess
Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 1 In… Heteromer
P01308;
32-852
Assess
Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry Heteromer
P01308; P01318;
28-847
NAG;NAG;NAG;NAG;NAG;
Assess
Insulin Receptor ectodomain in complex with one insulin molecule Heteromer
P01308; P01318;
28-847
Assess
Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists Heteromer
P01308;
28-847
NAG;NAG;NAG;NAG;NAG;
Assess
Leucine-zippered human insulin receptor ectodomain with single bound insulin - "upper" membrane-dis… Heteromer
P01308;
28-757
NAG;NAG;
Assess
The insulin receptor ectodomain in complex with a venom hybrid insulin analog - "head" region Heteromer
P01308;
28-757
NAG; 12×NAG;
Assess
Insulin Receptor ectodomain in complex with two insulin molecules Heteromer
P01308; P01318;
28-746
NAG;NAG;NAG;NAG;NAG;
Assess
Cryo-EM structure of full-length insulin receptor bound to 4 insulin. 3D refinement was focused on … Heteromer
A6XGL2;
28-744
Assess
Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 Heteromer
P01308;
31-746
NAG;NAG;NAG;
Assess
Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 Heteromer
A0A0B5A8Q2; A0A0B5AC95;
32-746
NAG;NAG;NAG;SO4;
Assess
Insulin in complex with Site 1 of the human insulin receptor Heteromer
P01308;
32-746
NAG;NAG;NAG;
Assess
Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SC… Heteromer
P01308;
33-745
NAG;NAG;NAG;SO4;GOL;NAG;
Assess
Cryo-EM Structure for the Insulin Binding Region in the Ectodomain of the Full-length Human Insulin… Heteromer
P01308;
32-744
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha… Heteromer
P01308;
32-742
NAG;NAG;NAG;
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… Heteromer
P01308;
32-742
NAG;NAG;NAG;
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… Heteromer
P01308;
32-742
NAG;NAG;NAG;
Assess
Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in c… Heteromer
P01317;
28-620
NAG;NAG;
Assess
Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin… Heteromer
P05019; P08069;
335-745
NAG;NAG;BMA;NAG;
Assess
Insulin-like growth factor I in complex with site 1 of a hybrid insulin receptor / Type 1 insulin-l… Heteromer
P05019; P08069;
28-336
NAG;NAG;SO4;NAG;
Assess
Structure of the endoglycosidase-H treated L1-CR domains of the human insulin receptor in complex w… Heteromer
P15127;
32-336
NAG;NAG;SO4;
Assess
Crystal structure of the Grb14 BPS region in complex with the insulin receptor tyrosine kinase Heteromer
Q14449;
1011-1310
CA;
Assess
Phosphorylated insulin receptor tyrosine kinase in complex with (4-{[5-carbamoyl-4-(3-methylanilino… Heteromer
P35568;
1011-1310
S91;
Assess
Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv Heteromer
32-330
NAG;NAG;NAG;NAG;
Assess
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide Heteromer
P81122;
1014-1310
Assess
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB phosphopeptide Heteromer
P81122;
1014-1310
Assess
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide and ATP Heteromer
P81122;
1014-1310
MG;ATP;
Assess
Crystal structure of a complex between PTP1B and the insulin receptor tyrosine kinase Heteromer
P18031;
1014-1310
10×SO4;
Assess
Crystal Structure of the Insulin Receptor Kinase in Complex with the SH2 Domain of APS Heteromer
Q9Z200;
1014-1310
MN;112;
Assess
Structure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor Heteromer
P35568;
991-999
Assess
Leucine-zippered human insulin receptor ectodomain with single bound insulin - "lower" membrane-pro…homo-2-mer31-946
NAG;
Assess
Insulin receptor (domains 1-3)homo-2-mer31-497
NAG;NAG;NAG;NAG;NAG;NAG;NAG;SO4;P33; 19×GOL;
Assess
Crystal structure of the activated insulin receptor tyrosine kinase dimerhomo-2-mer1001-1310
ACP;MG;
Assess
PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOGhomo-2-mer1008-1310
MG;ANP;
Assess
Crystal structure of insulin receptor kinase domain in complex with cis-(R)-7-(3-(azetidin-1-ylmeth…monomer1005-1310
60O;EDO;
Assess
Crystal structure of a catalytic-loop mutant of the insulin receptor tyrosine kinasemonomer1005-1310
Assess
Insulin receptor kinase complexed with an inhibitormonomer1007-1309
GS2;
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTORmonomer1008-1310
EMC;
Assess
CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITORmonomer1008-1310
MG;112;
Assess
Crystal structure of insulin receptor kinase domain in complex with an inhibitor Irfin-1monomer1009-1309
IR1;
Assess
The Crystal structure of INSR Tyrosine Kinase in complex with the Inhibitor BI 885578monomer1010-1310
5JA;
Assess
Insulin receptor kinase complexed with an inhibitormonomer1011-1310
GS3;
Assess
CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASEmonomer1013-1310
MG;ACP;
Assess
Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitormonomer1017-1310
351;
Assess
Solution structure of the transmembrane domain of the insulin receptor in micellesmonomer940-988
Assess

8 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3geq.1.Amonomer0.651014-1300
41.42
Assess
7pg3.1.Bmonomer0.6328-946
100.00
Assess
7pg2.1.Bmonomer0.6228-946
100.00
Assess
7v3p.1.Bmonomer0.6233-944
54.68
Assess
7v3p.1.Amonomer0.6133-944
54.68
Assess
7pg4.1.Bmonomer0.5828-946
100.00
Assess
6jk8.1.Bmonomer0.5733-947
NAG;59.59
Assess
6jk8.1.Amonomer0.5733-950
59.59
Assess

6 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23geq.1.Amonomer0.651002-1288
41.42
Assess
Isoform 27pg3.1.Bmonomer0.6428-934
100.00
Assess
Isoform 27pg2.1.Bmonomer0.6328-934
100.00
Assess
Isoform 27pg4.1.Bmonomer0.5928-934
100.00
Assess
Isoform 26jk8.1.Amonomer0.5833-938
59.59
Assess
Isoform 26jk8.1.Bmonomer0.5733-935
NAG;59.59
Assess